Cite
MLA Citation
Shiming He et al.. “A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer.” Drug delivery, vol. 29, 2022, pp. 1243–1256. http://access.bl.uk/ark:/81055/vdc_100153752122.0x000036